Brief: Precision Biosciences Announces Return Of Programs And Conclusion Of Collaboration With Prevail Therapeutics
16/04/2024 22:03
April 16 (Reuters) - Precision BioSciences Inc DTIL.O :
* PRECISION BIOSCIENCES ANNOUNCES RETURN OF PROGRAMS AND
CONCLUSION OF COLLABORATION WITH PREVAIL THERAPEUTICS
* PRECISION BIOSCIENCES INC - PRECISION EXERCISED OPTION TO
REGAIN
CONTROL OF PROGRAMS
* PRECISION BIOSCIENCES INC: EXPECTED CASH RUNWAY INTO
SECOND HALF
OF 2026 ARE NOT IMPACTED
* PRECISION BIOSCIENCES INC - EXPLORING OPPORTUNITIES TO
DEVELOP
RETURNED PROGRAMS INDEPENDENTLY OR IN PARTNERSHIP WITH OTHERS
Source text for Eikon: ID:nBw6YMwjxa
Further company coverage: DTIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Precision Biosciences
See all newsPrecision BioSciences Inc reports results for the quarter ended June 30 - Earnings Summary
Precision BioSciences Q2 net loss widens on warrant liability charge
Precision BioSciences Inc expected to post a loss of 79 cents a share - Earnings Preview
Precision BioSciences Inc expected to post a loss of 79 cents a share - Earnings Preview
Brief: Precision Biosciences - Enters First Amendment To Loan And Security Agreement With Banc Of California - SEC Filing